World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02844595
Date of registration: 19/07/2016
Prospective Registration: No
Primary sponsor: University of Santiago de Compostela
Public title: Behavioural Activation Treatment for Smoking Cessation and Depressive Symptomatology: a Randomized Controlled Trial
Scientific title: Behavioural Activation Treatment for Smoking Cessation and Depressive Symptomatology: a Randomized Controlled Trial
Date of first enrolment: January 2016
Target sample size: 275
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02844595
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).  
Phase:  N/A
Countries of recruitment
Spain
Contacts
Name:     Elisardo BecoƱa
Address: 
Telephone:
Email:
Affiliation:  University of Santiago de Compostela
Key inclusion & exclusion criteria

Inclusion Criteria:

- 18 years of age or older who smoke at least 10 cigarettes per day

- Desire to participate voluntarily in the treatment offered to quit smoking

- Correctly fill out all the pretreatment assessment questionnaires

- Be able to provide written informed consent

Exclusion Criteria:

- To have a diagnosis of a severe mental disorder (bipolar disorder and / or psychotic
disorder)

- To have a substance use disorder (alcohol, cannabis, cocaine, heroin), different from
a tobacco use disorder

- To smoke rolling snuff, cigars, little cigars or other tobacco products

- To have participated in an effective psychological treatment to quit smoking during
the previous 12 months

- To have received other effective pharmacological treatment to quit smoking in the
previous 12 months (nicotine gum or patches, bupropion, varenicline)

- To have a physical pathology involving life threatening risks for the person who would
require immediate intervention in individual format (eg. Recent myocardial infarction,
pneumothorax, etc.)



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Smoking
Intervention(s)
Behavioral: Standard cognitive-behavioural smoking cessation treatment and behavioural activation
Behavioral: Standard cognitive-behavioural smoking cessation treatment
Primary Outcome(s)
Point-prevalence abstinence [Time Frame: 1 year]
Change from baseline in depressive symptoms on the Beck Depression Inventory-II (BDI-II) [Time Frame: 1 year]
Change from baseline in depressive symptoms on the Hamilton Depression Rating Scale [Time Frame: 1 year]
Secondary Outcome(s)
Reduction of cigarette consumption [Time Frame: 1 year]
Continuous abstinence [Time Frame: 1 year]
Change from baseline in the Environmental Reward Observation Scale (EROS) scores [Time Frame: 1 year]
Change from baseline in the Behavioural Activation for Depression Scale (BADS) scores [Time Frame: 1 year]
Secondary ID(s)
PSI2015-66755-R (MINECO/FEDER)
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history